BTP-114

N/A

Report date: 2024/11/08 20:00:30
NME

Base Information

Drug NameBTP-114
Drug Alias NameBTP-114
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA cross linking agents
TargetsDNA
Therapy Area/IndicationsProstatic NeoplasmsOvarian NeoplasmsPancreatic Neoplasms +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTarveda Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPlacon Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsOvarian NeoplasmsPancreatic Neoplasms +[4

Other Information

ATC CodeN/A
Related LinksN/A